SR

Sonali Ratnakar Mehendre

Active Director Director DIN 01222154
DIN 01222154 First appointment Apr 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2007
Shareholding value •••• Premium profile

About Sonali Ratnakar Mehendre

Data last updated:

Sonali Ratnakar Mehendre is a Director at Shuban Pharmaceuticals Private Limited (since 2007). The company operates in Pharma. Shuban Pharmaceuticals Private Limited reported revenue of ₹16.2 Lakh (FY 2025).

DIN 01222154
Primary Designation Director
Industry Pharma
First Appointment 24 Apr 2007
Oldest Company Age 19 yrs
Largest company Shuban Pharmaceuticals Private Limited · ₹16.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Apr 20072007₹16.2 Lakh (FY 2025)Active

Board colleagues of Sonali Ratnakar Mehendre

Directorship timeline

Open interactive timeline →
Shuban Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sonali Ratnakar Mehendre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonali Ratnakar Mehendre

Sonali Ratnakar Mehendre currently holds 1 directorship: Shuban Pharmaceuticals Private Limited (Director, since 24 Apr 2007, revenue ₹16.2 Lakh (FY 2025)).

Sonali Ratnakar Mehendre was first appointed on 24 Apr 2007 as Director at Shuban Pharmaceuticals Private Limited.

The current boards of Sonali Ratnakar Mehendre's companies include Ratnakar Pandarinath Mehendre (Shuban Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available